Kamada
Présence
Kamada est une société cotée sous le symbole boursier KMDA (IL).
Dirigeants
Voir l'organigramme avec ses 21 principaux dirigeants
Biographies les plus recherchées chez Kamada
Créer une alerte
pour suivre les mouvements de dirigeants chez Kamada.
Pharmacie
Kamada a 1 867 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- AstraZeneca has announced the acquisition of Fusion Pharma (publié le 23 mars 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publié le 19 mars 2024).
- Frontier Medicines vient d'annoncer une levée de fonds de 80 millions de dollars. (publié le 27 février 2024).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par Kamada
- Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability - Kamada Pharmaceuticals
- Kamada Issues 2024 CEO Letter to Shareholders - Kamada Pharmaceuticals
- Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024 Company to Host Conference Call at 8:30am ET - Kamada Pharmaceuticals
- Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years - Kamada Pharmaceuticals
- Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance - Kamada Pharmaceuticals
- Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023 Financial Results and Host Conference Call on November 13, 2023 - Kamada Pharmaceuticals
- Kamada Provides Corporate Update on its Israel Operations - Kamada Pharmaceuticals
- Kamada Announces Recent Achievements with CYTOGAM® including Availability of Product Manufactured by the Company for U.S Commercial Sale and Presentation of New Clinical Data - Kamada Pharmaceuticals
- News - Kamada Pharmaceuticals
- Kamada Reports Strong Second Quarter and First Half 2023 Financial Results; Reiterates 2023 Revenue and Profitability Guidance - Kamada Pharmaceuticals
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Kamada
- Kamada sur Wikipédia, Google News & Yahoo Finance en 1-click
- Kamada sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont Amir London 
